AstraZeneca reported core earnings for the fourth quarter just in want of consensus, however stated it expected double-digit percentage progress in 2024. Unilever posted a…
Continue Reading....AstraZeneca reported core earnings for the fourth quarter just in want of consensus, however stated it expected double-digit percentage progress in 2024. Unilever posted a…
Continue Reading....